Apparent mineralocorticoid excess (AME) |
Recessive |
Non-functional 11-β-hydroxy steroid dehydrogenase (11β-HSD Type 2) enzyme |
16q |
Glucocorticoid remediable aldosteronism (GRA) |
Dominant |
Hybrid aldosterone synthase (CYP11B2) enzyme expressed under ACTH control |
8p |
Hypertensive forms of congenital adrenal hyperplasia |
Recessive |
Non-functional forms of the corresponding hydroxylases |
8q21 and 10q24 |
(11-β and 17-α hydroxylase types) |
|
(CYP11B1 and CYP17A) |
|
Liddle's Syndrome (pseudo-aldosteronism) |
Dominant |
Constitutively expressed amiloride-sensitive sodium channel in distal nephron |
16p |